Patent details

Basic Information

Publication number:

EP3256580

PCT Application Number:

EP2016053052

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167076538

PCT Publication Number:

WO2016128558

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CYSTEINE PROTEASE

French Title of Invention:

CYSTÉINE PROTÉASE

German Title of Invention:

CYSTEINPROTEASE

SPC Number:

Dates

Filing date:

12/02/2016

Grant date:

06/07/2022

EP Publication Date:

20/12/2017

PCT Publication Date:

18/08/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/07/2022

EP B1 Publication Date:

06/07/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/02/2023

Expiration date:

12/02/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/06/2022

 

 

Name:

Hansa Biopharma AB

Address:

Box 785, 220 07 Lund, Sweden (SE)

Inventor

1

Name:

KJELLMAN, Christian

Address:

Sweden (SE)

2

Name:

NORDAHL, Emma

Address:

Sweden (SE)

3

Name:

JARNUM, Sofia

Address:

Sweden (SE)

Priority

Priority Number:

201502306

Priority Date:

12/02/2015

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

C12N 9/54; A61K 38/48;

Publication

European Patent Bulletin

Issue number:

202227

Publication date:

06/07/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages